Immunicum AB (publ) Announces Positive Topline Results from the Phase I/II Clinical Trial in GIST

What we doOur approachPipelineTechnologyPatient Stories
About usManagementBoardClinical Advisory BoardCareers
Newsroom
InvestorsPress releases

Back
Immunicum AB (publ) Announces Positive Topline Results from the Phase I/II Clinical Trial in GIST
 8:00:00 AM

Keep reading
Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022Read